Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 170

1.

Epidural hematoma with detachment of the dural sinuses.

Lapadula G, Caporlingua F, Paolini S, Missori P, Domenicucci M.

J Neurosci Rural Pract. 2014 Apr;5(2):191-4. doi: 10.4103/0976-3147.131680.

PMID:
24966568
[PubMed]
Free PMC Article
2.

ECMO: an alternative support for acute respiratory failure caused by tuberculosis?

Cogliandro V, Lapadula G, Bandera A, Muscatello A, Marcolin R, Abbruzzese C, Rona R, Gori A.

Int J Tuberc Lung Dis. 2014 Jul;18(7):879-81. doi: 10.5588/ijtld.13.0752.

PMID:
24902570
[PubMed - in process]
3.

The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis.

Spadaro A, Lubrano E, Marchesoni A, Cauli A, Cantini F, Carotti M, D'Angelo S, Grassi W, Lapadula G, Macchioni P, Mathieu A, Punzi L, Ramonda R, Salaffi F, Salvarani C, Scarpa R, Olivieri I.

Clin Exp Rheumatol. 2014 May 21. [Epub ahead of print]

PMID:
24850468
[PubMed - as supplied by publisher]
4.

Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations.

Iannone F, Cantini F, Lapadula G.

J Rheumatol Suppl. 2014 May;91:41-6. doi: 10.3899/jrheum.140101.

PMID:
24788999
[PubMed - in process]
5.

Adalimumab in the treatment of immune-mediated diseases.

Lapadula G, Marchesoni A, Armuzzi A, Blandizzi C, Caporali R, Chimenti S, Cimaz R, Cimino L, Gionchetti P, Girolomoni G, Lionetti P, Marcellusi A, Mennini FS, Salvarani C.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):33-48. Review.

PMID:
24774505
[PubMed - indexed for MEDLINE]
6.

anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab.

Armuzzi A, Lionetti P, Blandizzi C, Caporali R, Chimenti S, Cimino L, Gionchetti P, Girolomoni G, Lapadula G, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Cimaz R.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):11-32. Review.

PMID:
24774504
[PubMed - indexed for MEDLINE]
7.

The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.

Blandizzi C, Gionchetti P, Armuzzi A, Caporali R, Chimenti S, Cimaz R, Cimino L, Lapadula G, Lionetti P, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Girolomoni G.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):1-10. Review.

PMID:
24774503
[PubMed - indexed for MEDLINE]
8.

Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study.

Gotti D, Raffetti E, Albini L, Sighinolfi L, Maggiolo F, Di Filippo E, Ladisa N, Angarano G, Lapadula G, Pan A, Esposti AD, Fabbiani M, Focà E, Scalzini A, Donato F, Quiros-Roldan E; Master Cohort Group.

PLoS One. 2014 Apr 23;9(4):e94768. doi: 10.1371/journal.pone.0094768. eCollection 2014.

PMID:
24760049
[PubMed - in process]
Free PMC Article
9.

Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab.

Cantarini L, Lopalco G, Vitale A, Coladonato L, Rigante D, Lucherini OM, Lapadula G, Iannone F.

Clin Rheumatol. 2014 Apr 15. [Epub ahead of print]

PMID:
24733249
[PubMed - as supplied by publisher]
10.

A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy.

Notarnicola A, Iannone F, Lopalco G, Covelli M, Lapadula G.

Reumatismo. 2014 Mar 17;65(6):298-301. doi: 10.4081/reumatismo.2013.727.

PMID:
24705034
[PubMed - in process]
11.

Intra-articular therapy with tumor necrosis factor-α antagonists: an update.

Bello S, Bonali C, Serafino L, Rotondo C, Terlizzi N, Lapadula G.

Reumatismo. 2014 Mar 14;65(6):257-63. doi: 10.4081/reumatismo.2013.721.

PMID:
24705028
[PubMed - in process]
12.

Mycobacterium tuberculosis Beijing family: analysis of the epidemiological and clinical factors associated with an emerging lineage in the urban area of Milan.

Zanini F, Carugati M, Schiroli C, Lapadula G, Lombardi A, Codecasa L, Gori A, Franzetti F.

Infect Genet Evol. 2014 Jul;25:14-9. doi: 10.1016/j.meegid.2014.03.021. Epub 2014 Mar 30.

PMID:
24694826
[PubMed - in process]
13.

Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice.

Punzi L, Lapadula G, Mathieu A.

BioDrugs. 2014 Apr;28 Suppl 1:25-37. doi: 10.1007/s40259-013-0065-y.

PMID:
24687236
[PubMed - in process]
14.

Serum amyloid-A in Behçet's disease.

Vitale A, Rigante D, Lopalco G, Brizi MG, Caso F, Franceschini R, Denaro R, Galeazzi M, Punzi L, Iannone F, Lapadula G, Simpatico A, Marrani E, Costa L, Cimaz R, Cantarini L.

Clin Rheumatol. 2014 Mar 23. [Epub ahead of print]

PMID:
24659331
[PubMed - as supplied by publisher]
15.

The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper.

Fiorino G, Girolomoni G, Lapadula G, Orlando A, Danese S, Olivieri I; SIR, SIDeMaST, and IG-IBD.

Autoimmun Rev. 2014 Jul;13(7):751-5. doi: 10.1016/j.autrev.2014.02.004. Epub 2014 Mar 19. Review.

PMID:
24657898
[PubMed - indexed for MEDLINE]
16.

Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life.

Iannone F, Notarnicola A, Lopalco G, Lapadula G.

Joint Bone Spine. 2014 Mar 20. pii: S1297-319X(14)00033-5. doi: 10.1016/j.jbspin.2014.01.012. [Epub ahead of print] No abstract available.

PMID:
24656742
[PubMed - as supplied by publisher]
17.

Polymerization of ethylene by silica-supported dinuclear Cr(III) sites through an initiation step involving C-H bond activation.

Conley MP, Delley MF, Siddiqi G, Lapadula G, Norsic S, Monteil V, Safonova OV, Copéret C.

Angew Chem Int Ed Engl. 2014 Feb 10;53(7):1872-6. doi: 10.1002/anie.201308983. Epub 2014 Jan 21.

PMID:
24505006
[PubMed - in process]
18.

Pleomorphic rhabdomyosarcoma of the cerebellopontine angle in an adult: a review of literature.

Caporlingua F, Lapadula G, Antonelli M, Missori P.

BMJ Case Rep. 2014 Jan 30;2014. pii: bcr2013203257. doi: 10.1136/bcr-2013-203257.

PMID:
24481021
[PubMed - in process]
19.

Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.

Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, de Olalla PG, Guest J, Samji H, Castagna A, d'Arminio Monforte A, Skaletz-Rorowski A, Ramos J, Lapadula G, Mussini C, Force L, Meyer L, Lampe F, Boufassa F, Bucher HC, De Wit S, Burkholder GA, Teira R, Justice AC, Sterling TR, M Crane H, Gerstoft J, Grarup J, May M, Chêne G, Ingle SM, Sterne J, Obel N; Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

Clin Infect Dis. 2014 May;58(9):1312-21. doi: 10.1093/cid/ciu038. Epub 2014 Jan 22.

PMID:
24457342
[PubMed - in process]
20.

Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature.

La Torre F, Lapadula G, Cantarini L, Lucherini OM, Iannone F.

Clin Rheumatol. 2014 Jan 21. [Epub ahead of print]

PMID:
24445386
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk